Ranolazine Preserves and Improves Left Ventricular Ejection Fraction and Autonomic Measures When Added to Guideline-Driven Therapy in Chronic Heart Failure-Reference-Cited by-同舟云学术

Ranolazine Preserves and Improves Left Ventricular Ejection Fraction and Autonomic Measures When Added to Guideline-Driven Therapy in Chronic Heart Failure

Published:2014-01 Issue:2 Volume:9 Page:heartint.500021
ISSN:1826-1868
Container-title:Heart International
language:en
Short-container-title:Heart International

Author:

Murray Gary L.¹,Colombo Joseph²

Affiliation:

1. The Heart and Vascular Institute, Germantown, TN - USA

2. Department of Cardiology, Drexel University College of Medicine, and ANSAR Medical Technologies, Inc., Philadelphia, PA - USA

Publisher

Touch Medical Media, Ltd.

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.5301/heartint.5000219

Reference34 articles.

1. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

2. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

3. Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

5. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Ranolazine in Heart Failure-Current Concepts;The American Journal of Cardiology;2023-12

2. Current understanding of structural and molecular changes in diabetic cardiomyopathy;Life Sciences;2023-11

3. Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice;Biomedicines;2023-02-22

4. Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling;Clinics;2023-01

5. Cardiovascular Effects of Ranolazine and the Scope for Translational Research: A Current Review of Literature;Frontiers in Cardiovascular Drug Discovery;2022-11-09